The ACTA1 Gene Myopathy Scapulohumeroperoneal NGS Genetic DNA Test is a vital diagnostic tool for identifying genetic mutations linked to scapulohumeroperoneal myopathy.this test is crucial for individuals experiencing muscle weakness and related symptoms. It utilizes advanced NGS technology to provide accurate results, aiding in effective management and treatment options. With a turnaround time of 3 to 4 weeks, patients can expect timely insights into their genetic health.
- Call Anytime: +254 704 150555
- info@biopassiondiagnostics.co.ke
ACTA1 Gene Myopathy Scapulohumeroperoneal Genetic Test
Genetic Testing
ACTA1 Gene Myopathy Scapulohumeroperoneal Genetic Test
KSh 56,000.00
Regular price
KSh 47,600.00
Current price
-15%
What Is the ACTA1 Gene Myopathy Scapulohumeroperoneal Genetic Test?
The ACTA1 Gene Myopathy Scapulohumeroperoneal NGS Genetic DNA Test is a specialized genetic test that plays a crucial role in diagnosing scapulohumeroperoneal myopathy, a rare neuromuscular disorder. This test employs Next Generation Sequencing (NGS) technology to detect mutations in the ACTA1 gene, which are known to cause this condition. Understanding your genetic makeup is essential for managing symptoms effectively and making informed decisions about your health.
Who Should Consider This Test?
The ACTA1 Gene Myopathy test is recommended for individuals exhibiting symptoms such as:
- Progressive muscle weakness
- Difficulty in lifting the arms or walking
- Muscle cramps and stiffness
Additionally, those with a family history of scapulohumeroperoneal myopathy or related neurological disorders should consider this test as a proactive measure.
What Does the Test Detect or Measure?
This genetic test specifically measures mutations in the ACTA1 gene, which are responsible for the development of scapulohumeroperoneal myopathy. By identifying these mutations, the test helps in confirming a diagnosis and guiding treatment options.
What the Results May Show
Results from the ACTA1 Gene Myopathy test will provide insights into the presence or absence of mutations in the ACTA1 gene. A genetic counselor will assist in interpreting the results, discussing implications for treatment, and advising on family planning options if necessary.
Benefits or Clinical Value
- Accurate diagnosis of scapulohumeroperoneal myopathy.
- Informed treatment decisions based on genetic insights.
- Potential for personalized management plans.
- Understanding risk factors for family members.
Pricing
| Test Name | Current Price | Regular Price |
|---|---|---|
| ACTA1 Gene Myopathy Scapulohumeroperoneal Genetic Test | KSh 47,600.00 | KSh 56,000.00 |
Book the ACTA1 Gene Myopathy Scapulohumeroperoneal Genetic Test
Contact Biopassion Diagnostics to confirm sample requirements and schedule this test.
SKU: d9896106ca98 | Category: Genetic Testing